<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><id>http://publicationslist.org/data/t.vergou/atom.xml</id><title>Theognosia Vergou's Publications List</title>
<link rel="self" type="application/atom+xml" href="http://publicationslist.org/data/t.vergou/atom.xml"/><link rel="alternate" type="text/html" href="http://publicationslist.org/t.vergou"/><author><name>Theognosia Vergou</name><uri>http://publicationslist.org/t.vergou</uri></author><icon>$basepathfavicon.ico</icon><subtitle>Recent additions to Theognosia Vergou's PublicationsList.org page</subtitle><logo>http://publicationslist.org/publications.png</logo><updated>2011-04-28T10:51:08Z</updated>

<entry>
<id>http://publicationslist.org/t.vergou/refid15</id>
<updated>2011-04-28T10:49:29Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid15'/>
<title type='html'>Long-term infliximab treatment for refractory type III juvenile pityriasis rubra pilaris.</title>
<summary type='html'>Clio Dessinioti, Theognosia Vergou, Evaggelia Moustou, Andreas Katsambas, Christina Antoniou (2011)  &lt;i&gt;Eur J Dermatol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; :  &lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid11</id>
<updated>2011-02-03T08:38:05Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid11'/>
<title type='html'>Psoriasis: is it the tip of the iceberg for the quality of life of patients and their families?</title>
<summary type='html'>Objective  To evaluate the impact of psoriasis on patients' and their relatives' quality of life (QoL). Methods  Eighty patients with their accompanying family members were included in the study. For measuring health related QoL (HRQoL) of patients with psoriasis, two questionnaires were used: Short Form 36 Health Survey (SF-36) and EuroQol (EQ-5D). Disease-specific HRQoL was assessed by the D...&lt;br/&gt;&lt;br/&gt;A Tadros, T Vergou, Aj Stratigos, C Tzavara, M Hletsos, A Katsambas, C Antoniou (2011)  &lt;i&gt;J Eur Acad Dermatol Venereol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; :  &lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid12</id>
<updated>2011-04-08T09:27:44Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid12'/>
<title type='html'>Pathways of Lateral Spreading.</title>
<summary type='html'>In the case of topically applied substances, usually both lateral spreading and competitive penetration into the skin occur in parallel. In the present study, the pathways of lateral spreading were studied quantitatively and visually. The local distribution and lateral spreading of the UV filter substance butyl methoxydibenzoylmethane applied in an o/w emulsion was studied on the forearm and the b...&lt;br/&gt;&lt;br/&gt;U Jacobi, S Schanzer, H-J Weigmann, A Patzelt, T Vergou, W Sterry, J Lademann (2011)  &lt;i&gt;Skin Pharmacol Physiol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 24: 5 231-237&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid14</id>
<updated>2011-04-28T10:49:29Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid14'/>
<title type='html'>Association of thyroid autoimmunity with acne in adult women.</title>
<summary type='html'>Background  During the last decades an increase has been observed regarding acne in adults and especially women. Objective  To evaluate the association between thyroid disorder and the presence of post-adolescent acne in adult women, comparing with healthy controls. Methods  107 adult women with post-adolescent acne and 60 healthy controls were included. Complete blood count and standard bio...&lt;br/&gt;&lt;br/&gt;T Vergou, E Mantzou, P Tseke, Ae Moustou, A Katsambas, M Alevizaki, C Antoniou (2011)  &lt;i&gt;J Eur Acad Dermatol Venereol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; :  &lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid6</id>
<updated>2010-11-20T18:17:18Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid6'/>
<title type='html'>Autoimmunity by anti-tumour necrosis factor-alpha agents: the role of traditional therapies.</title>
<summary type='html'>C Antoniou, A E Moustou, T Vergou, A Stratigos, A Kalambokas, A D Katsambas (2010)  &lt;i&gt;J Eur Acad Dermatol Venereol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 24: 3 356-357&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid5</id>
<updated>2010-11-20T18:17:18Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid5'/>
<title type='html'>Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre.</title>
<summary type='html'>BACKGROUND: Infliximab, a chimeric monoclonal antibody, has been shown to be effective for moderate to severe psoriasis. Clinical experience with long-term infliximab therapy for psoriasis is accumulating, and it is therefore important to share our experience with its use in real-life clinical practice. OBJECTIVES: To report our experience with infliximab (Remicade; Schering Plough, Kenilworth, NJ...&lt;br/&gt;&lt;br/&gt;C Antoniou, I Stefanaki, A Stratigos, E Moustou, T Vergou, P Stavropoulos, G Avgerinou, D Rigopoulos, A D Katsambas (2010)  &lt;i&gt;Br J Dermatol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 162: 5 1117-1123&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid2</id>
<updated>2010-11-20T18:17:18Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid2'/>
<title type='html'>Etanercept: effectiveness and safety data of a retrospective study.</title>
<summary type='html'>C Antoniou, T Vergou, C Dessinioti, A J Stratigos, G Avgerinou, P Stavropoulos, A Katsambas (2010)  &lt;i&gt;J Eur Acad Dermatol Venereol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; :  &lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid3</id>
<updated>2010-11-20T18:17:18Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid3'/>
<title type='html'>Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib.</title>
<summary type='html'>Theognosia Vergou, Alexander J Stratigos, Eleni M Karapanagiotou, Athina E Matekovits, Kalliopi D Dilana, Sotirios Tsimboukis, Christina Antoniou, Vassiliki Chasapi, Kostas N Syrigos (2010)  &lt;i&gt;J Am Acad Dermatol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 63: 2 e56-e58&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid13</id>
<updated>2011-04-08T09:28:37Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid13'/>
<title type='html'>Central retinal vein occlusion following infliximab treatment for plaque-type psoriasis.</title>
<summary type='html'>Theognosia Vergou, Aikaterini E Moustou, Apostolos Maniateas, Alexander J Stratigos, Andreas Katsambas, Christina Antoniou (2010)  &lt;i&gt;Int J Dermatol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 49: 10 1215-1217&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid4</id>
<updated>2011-04-08T09:34:16Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid4'/>
<title type='html'>Sequential treatment with biologics: switching from efalizumab to etanercept in 35 patients with high-need psoriasis.</title>
<summary type='html'>Use of biological agents has been shown to be an efficacious approach in psoriasis, when traditional treatments fail. However, there are limited data on the effectiveness and safety of switching from one biological agent to another.&lt;br/&gt;&lt;br/&gt;C Antoniou, C Dessinioti, T Vergou, A J Stratigos, G Avgerinou, M Kostaki, A Katsambas (2010)  &lt;i&gt;J Eur Acad Dermatol Venereol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 24: 12 1413-1420&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid7</id>
<updated>2010-11-20T18:17:18Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid7'/>
<title type='html'>Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.</title>
<summary type='html'>A E Moustou, A J Stratigos, T Vergou, S Gregoriou, S Georgala, I Danopoulou (2009)  &lt;i&gt;J Eur Acad Dermatol Venereol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 23: 8 968-969&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid10</id>
<updated>2010-11-28T17:36:12Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid10'/>
<title type='html'>Targeting the IL-12/IL-23 cytokine family in the treatment of psoriatic disease. </title>
<summary type='html'>Both Interleukin (IL)-12 and IL-23 have important roles in psoriasis, a complex Th1 and Th17 mediated auto-immune disease. Although they share the subunit p40, they have different immunologic profiles. Targeting the two cytokines, particularly the common subunit, has been recently studied in the treatment of this sometimes severe disease. This article reviews mechanisms of the disease and some stu...&lt;br/&gt;&lt;br/&gt;T Vergou , XTV Lima, AB Kimball.  (2008)  &lt;i&gt;Exp Rev Dermatol&lt;/i&gt; 3: 4 453 - 463&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid9</id>
<updated>2010-11-20T18:17:18Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid9'/>
<title type='html'>Lack of response of alopecia areata to pimecrolimus cream.</title>
<summary type='html'>D Rigopoulos, S Gregoriou, C Korfitis, C Gintzou, T Vergou, A Katrinaki, D Kalogeromitros (2007)  &lt;i&gt;Clin Exp Dermatol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 32: 4 456-457&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/t.vergou/refid8</id>
<updated>2010-11-20T18:17:18Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/t.vergou#refid8'/>
<title type='html'>Should we consider hypohidrotic ectodermal dysplasia as a possible risk factor for malignant melanoma?</title>
<summary type='html'>BACKGROUND: Hypohidrotic ectodermal dysplasia (HED) is a rare multisystem disorder that typically affects hair, teeth, nails, and sweat glands in combination with abnormalities of ectodermal originated tissues. OBJECTIVE: To raise the issue of whether heightened awareness is required in the follow-up of pigmented lesions in patients with HED. METHODS/RESULTS: Two patients with HED are reported. Th...&lt;br/&gt;&lt;br/&gt;Stamatis Gregoriou, Dimitris Rigopoulos, Theognosia Vergou, Chrysovalantis Korfitis, George Menegakis, George Kontochristopoulos (2007)  &lt;i&gt;J Cutan Med Surg&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 11: 5 188-190&lt;br/&gt;</summary>
</entry>
</feed>
